FDG-PET has emerged as a powerful modality for evaluating skeletal metastasis and revolutionized the diagnosis and staging of patients with solid tumors especially when other diagnostic imaging methods such as bone scintigraphy, CT or MRI results are equivocal. Because tumor cells have increased rate of glucose metabolism metastatic lesions can be detected by FDG-PET/CT earlier than the time of altered anatomy.